Lumos Diagnostics Holdings Limited's latest marketcap:
As of 08/15/2025, Lumos Diagnostics Holdings Limited's market capitalization has reached $51.03 M. According to our data, Lumos Diagnostics Holdings Limited is the 30108th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 51.03 M |
| Revenue (ttm) | 14.67 M |
| Net Income (ttm) | -4,983,000 |
| Shares Out | 0 |
| EPS (ttm) | -0.01 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 07/31/2025 |
Lumos Diagnostics Holdings Limited's yearly market capitalization.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 08/15/2025 | $51.03 M | 183.59% | 30108 |
| 12/31/2024 | $16.21 M | -32.31% | 46694 |
| 12/29/2023 | $23.95 M | 249.55% | 45036 |
| 12/30/2022 | $6.85 M | -93.71% | 43340 |
| 12/31/2021 | $108.92 M | 41386 |
Company Profile
About Lumos Diagnostics Holdings Limited
Lumos Diagnostics Holdings Limited is a medical diagnostics company specializing in the development, manufacturing, and commercialization of point-of-care diagnostic products. The company operates in the United States and Australia, focusing on solutions for the diagnosis and management of infectious diseases.
Key Products
- FebriDx – A rapid point-of-care diagnostic test designed to detect and differentiate between viral and bacterial respiratory infections.
- ViraDx – A three-in-one point-of-care test that identifies influenza A, influenza B, and COVID-19.
- Lumos Leelu – A disposable, hand-held reader that enhances diagnostic accuracy and efficiency.
Company Background
Founded in 2018, Lumos Diagnostics Holdings Limited is headquartered in Carlsbad, California, and continues to innovate in the field of rapid diagnostic testing.
Frequently Asked Questions
-
What is Lumos Diagnostics Holdings Limited's (OTC-LDXHF) current market cap?As of 08/15/2025, Lumos Diagnostics Holdings Limited (including the parent company, if applicable) has an estimated market capitalization of $51.03 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Lumos Diagnostics Holdings Limited (OTC-LDXHF) rank globally by market cap?Lumos Diagnostics Holdings Limited global market capitalization ranking is approximately 30108 as of 08/15/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.